MICA and breast cancer: As we could not compare flow cytometry data with WB analysis in plasma from lung cancer patients, since no bands could be obtained for our molecules of interest, EpCAM and MICA, samples with higher expected content of these proteins on EVs, ovarian and breast cancer-derived plasma and ascitic fluid, were also analysed.